Silver Partners 2019/2020
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.
Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Moreover, for the tenth consecutive year, Roche has been recognised as the most sustainable company in the Pharmaceuticals Industry by the Dow Jones Sustainability Indices (DJSI).
The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2018 employed about 94,000 people worldwide. In 2018, Roche invested CHF 11 billion in R&D and posted sales of CHF 56.8 billion. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan.
The family-owned and managed Dreier AG is a leading logistics provider in Switzerland. Founded in 1905 in Suhr, Switzerland. Since then, the company had a sustainable and steady growth over its long history. With its newest acquisition in 2019, the Dreier AG becomes the market leader in the handling of hanging garments in Switzerland.
Today the Dreier AG is still headquartered in Suhr and has branches in all language regions of Switzerland as well as subsidiary companies in Luxembourg, Germany, Spain and Morocco. As a group, Dreier employs about 550 people, has 280 own vehicles in varying configurations and approximately 650 swap bodies. In 2018 the group reached a turnover of 100 million CHF for its first time.
The company is an expert for national and international logistic solutions and has key competencies in the area of: intermodal transport, warehousing, conventional transport (cooled or uncooled) and crane operations in combination with building site deliveries. Also, it is fully certified by GDP to be a carrier and do warehousing for pharmaceutical products.
Dreier is highly committed towards the reduction of pollution and works efficiently to reduce its impact. Therefore, the company is determined to provide the customer with an optimal economical and ecological solution with strong emphasis on intermodal transport in cooperation with rail whenever possible. Also, the whole lorry fleet conforms to the highest European emission standards of today (Euro 6) and the average age is no older than three years.
Furthermore, Dreier is looking actively into the future and plans to invest in new and alternative propulsion systems like E-trucks or H² energy-based solutions. The company is very interested in the first tests and will invest in the latter one by 2021.